Company profileNutraceutical & supplements#739 of 1,318 in Pakistan✓ No DRAP alerts

OCU CARE

Nutraceutical & supplement manufacturer · 12 registered products

Ranked #11 of 32 companies in Antiinflammatory Agents And Antiinfectives In Combination

12 registered products 15 distinct molecules 0 DRAP alerts

12 of this company's registrations sit in the DRAP category “Eye”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

registered products

distinct molecules

therapeutic classes

DRAP alerts

OCU CARE is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 12 product registrations. Its portfolio is concentrated in Antiinflammatory Agents And Antiinfectives In Combination and Anti-Infective, Ophthalmologicals. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Eye11 brands

Dexamethasone3 brands

Tobramycin2 brands

Tetrahydrozoline2 brands

Chloramphenicol2 brands

Prednisolone Tebutate1 brand

Prednisolone1 brand

Moxifloxacin1 brand

Ofloxacin1 brand

Cefixime1 brand

Therapeutic classes

Regulatory record

✓

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

JAENS PHARMACEUTICAL INDUSTRIES PVT LTD11 shared molecules

INNVOTEK PHARMACEUTICALS10 shared molecules

VEGA PHARMACEUTICALS LTD.10 shared molecules

HELIX PHARMA (PRIVATE) LIMITED9 shared molecules

Atco Pharma International (Pvt) Ltd9 shared molecules

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.9 shared molecules

Sante (Private) Limited9 shared molecules

The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd.8 shared molecules

Barrett Hodgson Pakistan (Private) Ltd.8 shared molecules

Medipak (Pvt) Ltd8 shared molecules

Get the full profile for OCU

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included